Guidant (GDT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lighthouse who wrote (197)	6/20/2002 4:09:19 PM
From: Lighthouse	Read Replies (1) of 235

Do not believe everything you read from posters. I could be stupid, lazy and most importantly - wrong. I believe I have seen this picture before: STJ at $22 in 2000 BSX at $13 in November 2000 Now I guess it is GDT's turn. I now peg GDT's price to "Raw Cash Flow" at apx. 16 to 17. By comparison MDT is at apx. 43 times "raw cash flow" and BSX is at apx. 32.76 "raw cash flow". GDT's # is about as low as I have ever seen it. Also if a eliminate the stent division entirely - I still get a DCF value above the current price. Amazing. If everolimus works, a big IF at this point, in 2005. No way this stock stays at $30.50. I like the upside/downside at these levels. Cheers,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next